Comprehensive Genomic Profiling Reveals Clinical Associations in Response to Immune Therapy in Head and Neck Cancer

SIMPLE SUMMARY: The response rate of head and neck cancer (HNC) to immune checkpoint inhibitors (ICIs) can be as low as 20%. Biomarkers need to be elucidated to predict therapeutic response. Comprehensive genomic profiling (CGP) provides information on cancer-related genetic aberrations. Among the 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Noji, Rika, Tohyama, Kohki, Kugimoto, Takuma, Kuroshima, Takeshi, Hirai, Hideaki, Tomioka, Hirofumi, Michi, Yasuyuki, Tasaki, Akihisa, Ohno, Kazuchika, Ariizumi, Yosuke, Onishi, Iichiroh, Suenaga, Mitsukuni, Mori, Takehiko, Okamoto, Ryuichi, Yoshimura, Ryoichi, Miura, Masahiko, Asakage, Takahiro, Miyake, Satoshi, Ikeda, Sadakatsu, Harada, Hiroyuki, Kano, Yoshihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315472/
https://www.ncbi.nlm.nih.gov/pubmed/35884537
http://dx.doi.org/10.3390/cancers14143476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315472/
https://www.ncbi.nlm.nih.gov/pubmed/35884537
http://dx.doi.org/10.3390/cancers14143476

Ejemplares similares